Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Pharmaxis Ltd ( (AU:SNT) ) has issued an update.
Syntara Limited has announced a new issuance of 44,028,744 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX) on February 20, 2025. This issuance is a part of previously announced transactions and reflects Syntara Limited’s strategic financial maneuvers to enhance its market presence and potentially fortify its capital structure, thus impacting its stakeholders and industry positioning.
More about Pharmaxis Ltd
YTD Price Performance: 7.50%
Average Trading Volume: 5,375,335
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$135.8M
For detailed information about SNT stock, go to TipRanks’ Stock Analysis page.